|
2006P-0533: ANDA Suitability for Sterile Vancomycin Hydrochloride
USP, 750 mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 12/22/2006
|
| 12/27/2006
|
| Private Industry
|
| King & Spalding
LLP
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Christina M. Markus
|
|
|
|
|
| ACK1
|
| 12/27/2006
|
| 12/27/2006
|
| Federal Government
|
| FDA/DDM to King &
Spalding LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
| C1
|
| 07/12/2007
|
| 07/09/2007
|
| Private Industry
|
| King & Spalding
LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Christina M. Markus
| |
|
|
Top
| Up
Page last updated:
July 16, 2007
|
